Imax Diagnostic Imaging is a vertically integrated company combining more than 20 years of leadership in chemical synthesis and manufacturing of generics Active Pharmaceutical Ingredients and Drug Products.

Contrast Media has been always a key strategic area for Imax Diagnostic Imaging.

With the strategic decision in 2011 to differentiate the contrast media business of a traditional API player, capitalizing from the long term experience of manufacturing high quality generic contrast agents API’s, Imax Diagnostic Imaging was established with the objective to enter into the Final Drug Product generic contrast media market with full integration of the supply chain from raw materials chemical engineering post processing to drug product manufacturing, packaging and distribution to patient prep drug administration.